Home / Latest Reports / Diabetic Lancing Device Market

Diabetic Lancing Device Market By Type, Penetration Depth, Gauge and End User - Global Industry Analysis And Forecast To 2027

Published On : November 2018 Pages : 140 Category: Medical Devices Report Code : HC111730

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Diabetic Lancing Device Market By Type (Safety Lancets and Standard Lancets), Penetration Depth (2.5 mm to 3.0 mm, 2.1 mm to 2.5 mm, 1.6 mm to 2.0 mm, 1.1 mm to 1.5 mm, 0.8 mm to 1.0 mm and Other Penetration Depths), Gauge (30g, 28g, 25g, 23g, 21g, 17/18g and Other Gauges) and End User (Research & Academic Laboratories, Hospitals & Clinics, Home Care & Home Diagnostics, Diagnostic Centers & Medical Institutions and Other End Users) - Global Industry Analysis And Forecast To 2027         

Industry Outlook

The lancing gadget holds the lancet that is utilized to puncture a small hole in the skin for obtaining small amount of blood for testing the level of glucose in the blood. The devices of lancing are the reusable devices, while the lancet is just for single utilization. The utilization of the lancing devices is easy to use & growing preference for personal use. Increasing number of cases related to diabetes is increasing the demand & adoption of products & devices for controlling & monitoring the disorders. Increasing development in the technology used for testing blood glucose level. Therefore, the Diabetic Lancing Device Market is anticipated to expand and has tremendous scope during the forecast period. The global Diabetic Lancing Device Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Drivers & Restrains

The driving factors of the market are; increasing number of cases related to diabetes across the globe, rising awareness amongst the population about the monitoring devices used for testing the level of blood glucose, rising awareness about the infections that may spread if safety is not kept in mind, increasing number of initiatives by the government like the changes in policies related to reimbursement, growing technological development in the devices used of these procedures and various other factors. The restraining factor of the market is the increasing cost of the devices.

Regional Insights

The European region is leading the global Diabetic Lancing Device Market owing to rapid change in the lifestyle of the population and increasing research & development activities for developing new medications.

Diabetic Lancing Device Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • HTL-STREFA S.A
  • Terumo Corporation
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Greiner Bio One
  • Becton Dickinson
  • Sarstedt AG & Co.
  • F. Hoffmann-La Roche AG
  • Sanofi
  • Ypsomed Holding AG
  • Bayer AG
  • Medtronic
  • Eli Lilly and Company
  • Novo Nordisk A/S Owen Mumford Ltd.

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Diabetic Lancing Device Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o   Safety Lancets

o   Standard Lancets

o   Diabetic Lancing Device Market, By Penetration Depth, Estimates and Forecast, 2017-2027 ($Million)

o   2.5 mm to 3.0 mm

o   2.1 mm to 2.5 mm

o   1.6 mm to 2.0 mm

o   1.1 mm to 1.5 mm

o   0.8 mm to 1.0 mm

o   Other Penetration Depths

o   Diabetic Lancing Device Market, By Gauge, Estimates and Forecast, 2017-2027 ($Million)

o   30g

o   28g

o   25g

o   23g

o   21g

o   17/18g

o   Other Gauges

o   Diabetic Lancing Device Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Research & Academic Laboratories

o   Hospitals & Clinics

o   Home Care & Home Diagnostics

o   Diagnostic Centers & Medical Institutions

o   Other End Users

o   Diabetic Lancing Device Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Diabetic Lancing Device Market, By Country

o   U.S. Diabetic Lancing Device Market

o   Canada Diabetic Lancing Device Market

o   Mexico Diabetic Lancing Device Market

o   Europe

§  Europe Diabetic Lancing Device Market, By Country

o   Germany Diabetic Lancing Device Market

o   UK Diabetic Lancing Device Market

o   France Diabetic Lancing Device Market

o   Russia Diabetic Lancing Device Market

o   Italy Diabetic Lancing Device Market

o   Rest of Europe Diabetic Lancing Device Market

o   Asia-Pacific

§  Asia-Pacific Diabetic Lancing Device Market, By Country

o   China Diabetic Lancing Device Market

o   Japan Diabetic Lancing Device Market

o   South Korea  Diabetic Lancing Device Market

o   India Diabetic Lancing Device Market

o   Southeast Asia Diabetic Lancing Device Market

o   Rest of Asia-Pacific Diabetic Lancing Device Market

o   South America

§  South America Diabetic Lancing Device Market, By Country

o   Brazil Diabetic Lancing Device Market

o   Argentina Diabetic Lancing Device Market

o   Columbia Diabetic Lancing Device Market

o   Rest of South America Diabetic Lancing Device Market

o   Middle East and Africa

§  Middle East and Africa Diabetic Lancing Device Market, By Country

o   Saudi Arabia Diabetic Lancing Device Market

o   UAE Diabetic Lancing Device Market

o   Egypt Diabetic Lancing Device Market

o   Nigeria Diabetic Lancing Device Market

o   South Africa Diabetic Lancing Device Market

o   Rest of MEA Diabetic Lancing Device Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Diabetic Lancing Device  Market, By Type

5.1.     Introduction

5.2.     Global Diabetic Lancing Device  Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Diabetic Lancing Device  Revenue and Revenue Share by Type (2017-2027)

5.3.     Safety Lancets

5.3.1.  Global Safety Lancets  Revenue and Growth Rate (2017-2027)

5.4.     Standard Lancets

5.4.1.  Global Standard Lancets Revenue and Growth Rate (2017-2027)

6.       Diabetic Lancing Device  Market, By Penetration Depth

6.1.     Introduction

6.2.     Global Diabetic Lancing Device  Revenue and Market Share by Penetration Depth (2017-2027)

6.2.1.  Global Diabetic Lancing Device  Revenue and Revenue Share by Penetration Depth (2017-2027)

6.3.     2.5 mm to 3.0 mm

6.3.1.  Global 2.5 mm to 3.0 mm  Revenue and Growth Rate (2017-2027)

6.4.     2.1 mm to 2.5 mm

6.4.1.  Global 2.1 mm to 2.5 mm Revenue and Growth Rate (2017-2027)

6.5.     1.6 mm to 2.0 mm

6.5.1.  Global 1.6 mm to 2.0 mm  Revenue and Growth Rate (2017-2027)

6.6.     1.1 mm to 1.5 mm

6.6.1.  Global 1.1 mm to 1.5 mm Revenue and Growth Rate (2017-2027)

6.7.     0.8 mm to 1.0 mm

6.7.1.  Global 0.8 mm to 1.0 mm  Revenue and Growth Rate (2017-2027)

6.8.     Other Penetration Depths

6.8.1.  Global Other Penetration Depths Revenue and Growth Rate (2017-2027)

7.       Diabetic Lancing Device  Market, By Gauge

7.1.     Introduction

7.2.     Global Diabetic Lancing Device  Revenue and Market Share by Gauge (2017-2027)

7.2.1.  Global Diabetic Lancing Device  Revenue and Revenue Share by Gauge (2017-2027)

7.3.     30g

7.3.1.  Global 30g  Revenue and Growth Rate (2017-2027)

7.4.     28g

7.4.1.  Global 28g Revenue and Growth Rate (2017-2027)

7.5.     25g

7.5.1.  Global 25g Revenue and Growth Rate (2017-2027)

7.6.     23g

7.6.1.  Global 23g Revenue and Growth Rate (2017-2027)

7.7.     21g

7.7.1.  Global 21g Revenue and Growth Rate (2017-2027)

7.8.     17/18g

7.8.1.  Global 17/18g Revenue and Growth Rate (2017-2027)

7.9.     Other Gauges

7.9.1.  Global Other Gauges Revenue and Growth Rate (2017-2027)

8.       Diabetic Lancing Device  Market, By End User

8.1.     Introduction

8.2.     Global Diabetic Lancing Device  Revenue and Market Share by End User (2017-2027)

8.2.1.  Global Diabetic Lancing Device  Revenue and Revenue Share by End User (2017-2027)

8.3.     Research & Academic Laboratories

8.3.1.  Global Research & Academic Laboratories  Revenue and Growth Rate (2017-2027)

8.4.     Hospitals & Clinics

8.4.1.  Global Hospitals & Clinics  Revenue and Growth Rate (2017-2027)

8.5.     Home Care & Home Diagnostics

8.5.1.  Global Home Care & Home Diagnostics Revenue and Growth Rate (2017-2027)

8.6.     Diagnostic Centers & Medical Institutions

8.6.1.  Global Diagnostic Centers & Medical Institutions Revenue and Growth Rate (2017-2027)

8.7.     Other End Users

8.7.1.  Global Other End Users Revenue and Growth Rate (2017-2027)

9.       Diabetic Lancing Device  Market, By Region

9.1.     Introduction

9.2.     Global Diabetic Lancing Device  Revenue and Market Share by Regions

9.2.1.  Global Diabetic Lancing Device  Revenue by Regions (2017-2027)

9.3.     North America Diabetic Lancing Device  by Countries

9.3.1.  North America Diabetic Lancing Device  Revenue and Growth Rate (2017-2027)

9.3.2.  North America Diabetic Lancing Device  Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Diabetic Lancing Device  by Countries

9.4.1.  Europe Diabetic Lancing Device  Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Diabetic Lancing Device  Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Diabetic Lancing Device  by Countries

9.5.1.  Asia-Pacific Diabetic Lancing Device  Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Diabetic Lancing Device  Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Diabetic Lancing Device  by Countries

9.6.1.  South America Diabetic Lancing Device  Revenue and Growth Rate (2017-2027)

9.6.2.  South America Diabetic Lancing Device  Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Diabetic Lancing Device  by Countries

9.7.1.  Middle East and Africa Diabetic Lancing Device  Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Diabetic Lancing Device  Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. HTL-STREFA S.A

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. Terumo Corporation

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Abbott Laboratories

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. B. Braun Melsungen AG

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. Greiner Bio One

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Becton Dickinson

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. Sarstedt AG & Co.

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. F. Hoffmann-La Roche AG

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. Sanofi

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

10.10.                   Ypsomed Holding AG

10.10.1.  Business Overview

10.10.2.   Service Portfolio

10.10.3.  Strategic Developments

10.10.4.   Revenue and Market Share

10.11.                   Bayer AG

10.11.1.  Business Overview

10.11.2.   Service Portfolio

10.11.3.  Strategic Developments

10.11.4.   Revenue and Market Share

10.12.                   Medtronic

10.12.1.  Business Overview

10.12.2.   Service Portfolio

10.12.3.  Strategic Developments

10.12.4.   Revenue and Market Share

10.13.                   Eli Lilly and Company

10.13.1.  Business Overview

10.13.2.   Service Portfolio

10.13.3.  Strategic Developments

10.13.4.   Revenue and Market Share

10.14.                   Novo Nordisk A/S Owen Mumford Ltd.

10.14.1.  Business Overview

10.14.2.   Service Portfolio

10.14.3.  Strategic Developments

10.14.4.   Revenue and Market Share

11.    Global Diabetic Lancing Device  Market Competition, by Manufacturer

11.1. Global Diabetic Lancing Device  Revenue and Market Share by Manufacturer (2017-2017)

11.2. Top 5 Diabetic Lancing Device  Manufacturer Market Share

11.3. Market Competition Trend

12.    Diabetic Lancing Device  Market Forecast (2017-2027)

12.1. Global Diabetic Lancing Device  Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Diabetic Lancing Device  Market Forecast by Regions (2017-2027)

12.2.1.      North America Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.1.1. United States Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.1.2. Canada Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.1.3. Mexico Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.      Europe Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.1. Germany Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.2. France Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.3. UK Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.4. Russia Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.5. Italy Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.1. China Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.2. Japan Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.3. Korea Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.4. India Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.4.      South America Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.4.1. Brazil Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.4.2. Argentina Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.4.3. Columbia Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.4.4. Rest of South America Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.3. Egypt Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.4. Nigeria Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.5. South Africa Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.6. Turkey Diabetic Lancing Device  Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Diabetic Lancing Device  Market Forecast (2017-2027)

12.3. Diabetic Lancing Device  Market Forecast by Type (2017-2027)

12.3.1.      Diabetic Lancing Device  Forecast by Type (2017-2027)

12.3.2.      Diabetic Lancing Device  Market Share Forecast by Type (2017-2027)

12.4. Diabetic Lancing Device  Market Forecast by Penetration Depth (2017-2027)

12.4.1.      Diabetic Lancing Device  Forecast by Penetration Depth (2017-2027)

12.4.2.      Diabetic Lancing Device  Market Share Forecast by Penetration Depth (2017-2027)

12.5. Diabetic Lancing Device  Market Forecast by Gauge (2017-2027)

12.5.1.      Diabetic Lancing Device  Forecast by Gauge (2017-2027)

12.5.2.      Diabetic Lancing Device  Market Share Forecast by Gauge (2017-2027)

12.6. Diabetic Lancing Device  Market Forecast by End User (2017-2027)

12.6.1.      Diabetic Lancing Device  Forecast by End User (2017-2027)

12.6.2.      Diabetic Lancing Device  Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Diabetic Lancing Device Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Diabetic Lancing Device Revenue and Revenue Share by Type (2017-2018)
Figure Global Safety Lancets Revenue and Growth Rate (2017-2018)
Figure Global Standard Lancets Revenue and Growth Rate (2017-2018)
Table Global Diabetic Lancing Device Revenue and Revenue Share by Penetration Depth (2017-2018)
Figure Global 2.5 mm to 3.0 mm Revenue and Growth Rate (2017-2018)
Figure Global 2.1 mm to 2.5 mm Revenue and Growth Rate (2017-2018)
Figure Global 1.6 mm to 2.0 mm Revenue and Growth Rate (2017-2018)
Figure Global 1.1 mm to 1.5 mm Revenue and Growth Rate (2017-2018)
Figure Global 0.8 mm to 1.0 mm Revenue and Growth Rate (2017-2018)
Figure Global Other Penetration Depths Revenue and Growth Rate (2017-2018)
Table Global Diabetic Lancing Device Revenue and Revenue Share by Gauge (2017-2018)
Figure Global 30g Revenue and Growth Rate (2017-2018)
Figure Global 28g Revenue and Growth Rate (2017-2018)
Figure Global 25g Revenue and Growth Rate (2017-2018)
Figure Global 23g Revenue and Growth Rate (2017-2018)
Figure Global 21g Revenue and Growth Rate (2017-2018)
Figure Global 17/18g Revenue and Growth Rate (2017-2018)
Figure Global Other Gauges Revenue and Growth Rate (2017-2018)
Table Global Diabetic Lancing Device Revenue and Revenue Share by End User (2017-2018)
Figure Global Research & Academic Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Hospitals & Clinics Revenue and Growth Rate (2017-2018)
Figure Global Home Care & Home Diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Centers & Medical Institutions Revenue and Growth Rate (2017-2018)
Figure Global Other End Users Revenue and Growth Rate (2017-2018)
Table Global Diabetic Lancing Device Revenue by Regions (2017-2018)
Figure North America Diabetic Lancing Device Growth Rate (2017-2018)
Figure North America Diabetic Lancing Device Revenue and Growth Rate (2017-2018)
Figure North America Diabetic Lancing Device by Countries (2017-2018)
Figure North America Diabetic Lancing Device Revenue (Million USD) by Countries (2017-2018)
Figure United States Diabetic Lancing Device Growth Rate (2017-2018)
Figure United States Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Diabetic Lancing Device Growth Rate (2017-2018)
Figure Canada Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Diabetic Lancing Device Growth Rate (2017-2018)
Figure Mexico Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Diabetic Lancing Device Growth Rate (2017-2018)
Figure Europe Diabetic Lancing Device Revenue and Growth Rate (2017-2018)
Figure Europe Diabetic Lancing Device by Countries (2017-2018)
Figure Europe Diabetic Lancing Device Revenue (Million USD) by Countries (2017-2018)
Figure Germany Diabetic Lancing Device Growth Rate (2017-2018)
Figure Germany Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Diabetic Lancing Device Growth Rate (2017-2018)
Figure France Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Diabetic Lancing Device Growth Rate (2017-2018)
Figure UK Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Diabetic Lancing Device Growth Rate (2017-2018)
Figure Russia Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Diabetic Lancing Device Growth Rate (2017-2018)
Figure Italy Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Diabetic Lancing Device Growth Rate (2017-2018)
Figure Rest of Europe Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Diabetic Lancing Device Growth Rate (2017-2018)
Figure Asia-Pacific Diabetic Lancing Device Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Diabetic Lancing Device by Countries (2017-2018)
Figure Asia-Pacific Diabetic Lancing Device Revenue (Million USD) by Countries (2017-2018)
Figure China Diabetic Lancing Device Growth Rate (2017-2018)
Figure China Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Diabetic Lancing Device Growth Rate (2017-2018)
Figure Japan Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Diabetic Lancing Device Growth Rate (2017-2018)
Figure Korea Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Diabetic Lancing Device Growth Rate (2017-2018)
Figure India Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Diabetic Lancing Device Growth Rate (2017-2018)
Figure Southeast Asia Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Diabetic Lancing Device Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Diabetic Lancing Device Growth Rate (2017-2018)
Figure South America Diabetic Lancing Device Revenue and Growth Rate (2017-2018)
Figure South America Diabetic Lancing Device by Countries (2017-2018)
Figure South America Diabetic Lancing Device Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Diabetic Lancing Device Growth Rate (2017-2018)
Figure Brazil Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Diabetic Lancing Device Growth Rate (2017-2018)
Figure Argentina Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Diabetic Lancing Device Growth Rate (2017-2018)
Figure Columbia Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Diabetic Lancing Device Growth Rate (2017-2018)
Figure Rest of South America Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Diabetic Lancing Device Growth Rate (2017-2018)
Figure Middle East and Africa Diabetic Lancing Device Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Diabetic Lancing Device by Countries (2017-2018)
Figure Middle East and Africa Diabetic Lancing Device Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Diabetic Lancing Device Growth Rate (2017-2018)
Figure Saudi Arabia Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Diabetic Lancing Device Growth Rate (2017-2018)
Figure United Arab Emirates Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Diabetic Lancing Device Growth Rate (2017-2018)
Figure Egypt Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Diabetic Lancing Device Growth Rate (2017-2018)
Figure Nigeria Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Diabetic Lancing Device Growth Rate (2017-2018)
Figure South Africa Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Diabetic Lancing Device Growth Rate (2017-2018)
Figure Turkey Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Diabetic Lancing Device Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2017-2018)
Table HTL-STREFA S.A Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Terumo Corporation Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table B. Braun Melsungen AG Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Greiner Bio One Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Becton Dickinson Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sarstedt AG & Co. Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche AG Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ypsomed Holding AG Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer AG Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medtronic Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eli Lilly and Company Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novo Nordisk A/S Owen Mumford Ltd. Diabetic Lancing Device Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Diabetic Lancing Device Market Share by Manufacturer
Figure Global Diabetic Lancing Device Revenue and Market Share by Manufacturer
Table Global Diabetic Lancing Device Price by Region (2017-2017)
Figure Top 5 Diabetic Lancing Device Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Diabetic Lancing Device Revenue (Millions USD) and Growth Rate (2018-2025)
Table Diabetic Lancing Device Market Forecast by Regions (2018-2025)
Figure North America Diabetic Lancing Device Market Forecast (2018-2025)
Figure United States Diabetic Lancing Device Market Forecast (2018-2025)
Figure Canada Diabetic Lancing Device Market Forecast (2018-2025)
Figure Mexico Diabetic Lancing Device Market Forecast (2018-2025)
Figure Europe Diabetic Lancing Device Market Forecast (2018-2025)
Figure Germany Diabetic Lancing Device Market Forecast (2018-2025)
Figure France Diabetic Lancing Device Market Forecast (2018-2025)
Figure UK Diabetic Lancing Device Market Forecast (2018-2025)
Figure Russia Diabetic Lancing Device Market Forecast (2018-2025)
Figure Italy Diabetic Lancing Device Market Forecast (2018-2025)
Figure Rest of Europe Diabetic Lancing Device Market Forecast (2018-2025)
Figure Asia-Pacific Diabetic Lancing Device Market Forecast (2018-2025)
Figure China Diabetic Lancing Device Market Forecast (2018-2025)
Figure Japan Diabetic Lancing Device Market Forecast (2018-2025)
Figure Korea Diabetic Lancing Device Market Forecast (2018-2025)
Figure India Diabetic Lancing Device Market Forecast (2018-2025)
Figure Southeast Asia Diabetic Lancing Device Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Diabetic Lancing Device Market Forecast (2018-2025)
Figure South America Diabetic Lancing Device Market Forecast (2018-2025)
Figure Brazil Diabetic Lancing Device Market Forecast (2018-2025)
Figure Argentina Diabetic Lancing Device Market Forecast (2018-2025)
Figure Columbia Diabetic Lancing Device Market Forecast (2018-2025)
Figure Rest of South America Diabetic Lancing Device Market Forecast (2018-2025)
Figure Middle East and Africa Diabetic Lancing Device Market Forecast (2018-2025)
Figure Saudi Arabia Diabetic Lancing Device Market Forecast (2018-2025)
Figure United Arab Emirates Diabetic Lancing Device Market Forecast (2018-2025)
Figure Egypt Diabetic Lancing Device Market Forecast (2018-2025)
Figure Nigeria Diabetic Lancing Device Market Forecast (2018-2025)
Figure South Africa Diabetic Lancing Device Market Forecast (2018-2025)
Figure Turkey Diabetic Lancing Device Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Diabetic Lancing Device Market Forecast (2018-2025)
Figure Global Diabetic Lancing Device Forecast by Type (2018-2025)
Figure Global Diabetic Lancing Device Market Share Forecast by Type (2018-2025)
Figure Global Diabetic Lancing Device Forecast by Type (2018-2025)
Figure Global Diabetic Lancing Device Forecast by Penetration Depth (2018-2025)
Figure Global Diabetic Lancing Device Market Share Forecast by Penetration Depth (2018-2025)
Figure Global Diabetic Lancing Device Forecast by Penetration Depth (2018-2025)
Figure Global Diabetic Lancing Device Forecast by Gauge (2018-2025)
Figure Global Diabetic Lancing Device Market Share Forecast by Gauge (2018-2025)
Figure Global Diabetic Lancing Device Forecast by Gauge (2018-2025)
Figure Global Diabetic Lancing Device Forecast by End User (2018-2025)
Figure Global Diabetic Lancing Device Market Share Forecast by End User (2018-2025)
Figure Global Diabetic Lancing Device Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample